Evidence map›Paper›PMID 42865949›Full record

ArticleACS medicinal chemistry letters2026

Next Generation NMR Flow Tube Optimized for Small Volume NMR Reaction Monitoring in Preclinical Drug Discovery.

Kathleen A Farley, David Foley, Robert Krull, Martin Hoffman, Anna Codina, Peter Dorff, Christopher W Am Ende, Ormacinda White, Stephen W Wright

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kathleen A FarleyMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.ORCID https://orcid.org/0000-0001-8935-6852
David FoleyMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.ORCID https://orcid.org/0000-0003-2323-5307
Robert KrullBruker BioSpin, Billerica, Massachusetts 01821, United States.
Martin HoffmanBruker BioSpin, 76287 Rheinstetten, Germany.
Anna CodinaBruker UK Limited, Coventry CV4 8HX, UK.
Peter DorffMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.
Christopher W Am EndeMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.
Ormacinda WhiteMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.
Stephen W WrightMedicine Design, Pfizer Inc., 445 Eastern Point Rd, Groton, Connecticut 06340, United States.ORCID https://orcid.org/0000-0002-9785-5077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed a 3 mm NMR flow tube that can be inserted into a 5 mm NMR probe converting a high field NMR spectrometer into a reaction monitoring system with a minimum reaction volume of 2 mL. The system uses a standard LC pump to flow the reaction mixture from a reaction vial in an integrated heating block to the center of the magnet for detection before returning the mixture back to the vial. The NMR flow tube has a temperature range of -20 to 120 °C and the NMR instrument can be switched from NMR tubes to the flow tube mode in a few minutes. We report the use of this flow NMR small volume system to monitor the progress of two chemical reactions that resisted study by more common analytical techniques.

Indexed as

19F-NMR1H-NMRFlow NMRreaction monitoring

Identifiers

PMID42865949
PMCPMC13656274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.